CHICAGO – Researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will present data on the latest advances in clinical cancer research at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting from June 2-6 in Chicago, Illinois. Follow us on Twitter @PennMDForum and @PennCancer for updates.
Expert Interviews
Experts from the Perelman School of Medicine are available to comment on a wide range of topics in cancer science and medicine during the meeting on site and by video call, telephone, or email. To arrange interviews, please contact Meagan Raeke at Meagan.Raeke@pennmedicine.upenn.edu or 267-693-6224.
Incoming ASCO Leaders from Penn Medicine
ASCO President-Elect Lynn M. Schuchter, MD, FASCO , the Madlyn and Leonard Abramson Professor of Clinical Oncology and director of the Tara Miller Melanoma Center , will begin her term as ASCO President for 2023-2024 at the end of the Annual Meeting. Learn more about her election to the top professional society for cancer care .
In addition, Angela DeMichele, MD, MSCE , the Jill & Alan Miller Endowed Chair in Breast Cancer Excellence, will serve as chair of the Scientific Program Committee, and Charu Aggarwal, MD, MPH , the Leslye M. Heisler Associate Professor for Lung Cancer Excellence in Hematology-Oncology, will serve as chair of the Communications Committee for the 2024 ASCO Annual Meeting.
News Releases
Two Penn Medicine Abramson Cancer Center Faculty Members Receive Top ASCO Awards
Check back for additional news as embargos lift during the meeting.
Key Presentations
Penn Medicine researchers will present results from clinical trials for recurrent glioblastoma and metastatic HR+/HER2- breast cancer . Experts will also present studies focused on serious illness conversations for patients with cancer, the effect of Medicaid expansion on clinical trial enrollment, and infertility among female oncologists. Key presentations include:
Central Nervous System Tumors
Breast Cancer
Equity in Oncology
Health Services Research, Quality Improvement, Care Delivery and Regulatory Policy
###
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation’s first medical school) and the University of Pennsylvania Health System , which together form a $8.6 billion enterprise.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $494 million awarded in the 2019 fiscal year.
The University of Pennsylvania Health System’s patient care facilities include: the Hospital of the University of Pennsylvania and Penn Presbyterian Medical Center—which are recognized as one of the nation’s top “Honor Roll” hospitals by U.S. News & World Report—Chester County Hospital; Lancaster General Health; Penn Medicine Princeton Health; and Pennsylvania Hospital, the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is powered by a talented and dedicated workforce of more than 43,900 people. The organization also has alliances with top community health systems across both Southeastern Pennsylvania and Southern New Jersey, creating more options for patients no matter where they live.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2019, Penn Medicine provided more than $583 million to benefit our community.